BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24320143)

  • 1. Ligand-based virtual screening to predict inhibitors against metastatic lymph node 64.
    Chitrala KN; Yeguvapalli S
    J Recept Signal Transduct Res; 2014 Apr; 34(2):92-6. PubMed ID: 24320143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol interaction with the related steroidogenic acute regulatory lipid-transfer (START) domains of StAR (STARD1) and MLN64 (STARD3).
    Reitz J; Gehrig-Burger K; Strauss JF; Gimpl G
    FEBS J; 2008 Apr; 275(8):1790-802. PubMed ID: 18331352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormone synthesis in mitochondria.
    Miller WL
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):62-73. PubMed ID: 23628605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLN64 and MENTHO, two mediators of endosomal cholesterol transport.
    Alpy F; Tomasetto C
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):343-5. PubMed ID: 16709157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and lipid transport mechanism of a StAR-related domain.
    Tsujishita Y; Hurley JH
    Nat Struct Biol; 2000 May; 7(5):408-14. PubMed ID: 10802740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol.
    Murcia M; Faráldo-Gómez JD; Maxfield FR; Roux B
    J Lipid Res; 2006 Dec; 47(12):2614-30. PubMed ID: 16990645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding.
    Lavigne P; Najmanivich R; Lehoux JG
    Subcell Biochem; 2010; 51():425-37. PubMed ID: 20213553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein.
    Bose HS; Whittal RM; Ran Y; Bose M; Baker BY; Miller WL
    Biochemistry; 2008 Feb; 47(8):2277-88. PubMed ID: 18211099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals.
    Alpy F; Tomasetto C
    J Cell Sci; 2005 Jul; 118(Pt 13):2791-801. PubMed ID: 15976441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial heat shock protein participates in placental steroidogenesis.
    Olvera-Sanchez S; Espinosa-Garcia MT; Monreal J; Flores-Herrera O; Martinez F
    Placenta; 2011 Mar; 32(3):222-9. PubMed ID: 21232789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of chemical libraries.
    Shoichet BK
    Nature; 2004 Dec; 432(7019):862-5. PubMed ID: 15602552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites.
    Weill N; Rognan D
    J Chem Inf Model; 2010 Jan; 50(1):123-35. PubMed ID: 20058856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STARD5 specific ligand binding: comparison with STARD1 and STARD4 subfamilies.
    Létourneau D; Lefebvre A; Lavigne P; LeHoux JG
    Mol Cell Endocrinol; 2013 May; 371(1-2):20-5. PubMed ID: 23337244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of drug target proteins by 2D ligand matching approach.
    Feng J; Guo H; Wang J; Lu T
    Chem Biol Drug Des; 2014 Feb; 83(2):174-82. PubMed ID: 24034065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the putative cholesterol transport protein metastatic lymph node 64 in the brain.
    King SR; Smith AG; Alpy F; Tomasetto C; Ginsberg SD; Lamb DJ
    Neuroscience; 2006; 139(3):1031-8. PubMed ID: 16549269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
    Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
    J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of virtual high-throughput screening methods for the identification of phosphodiesterase-5 inhibitors.
    Niinivehmas SP; Virtanen SI; Lehtonen JV; Postila PA; Pentikäinen OT
    J Chem Inf Model; 2011 Jun; 51(6):1353-63. PubMed ID: 21591817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER.
    Alpy F; Rousseau A; Schwab Y; Legueux F; Stoll I; Wendling C; Spiegelhalter C; Kessler P; Mathelin C; Rio MC; Levine TP; Tomasetto C
    J Cell Sci; 2013 Dec; 126(Pt 23):5500-12. PubMed ID: 24105263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening.
    Huang N; Kalyanaraman C; Irwin JJ; Jacobson MP
    J Chem Inf Model; 2006; 46(1):243-53. PubMed ID: 16426060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.